How should a patient with newly presenting acute severe hypertension be evaluated and treated in the short term, what long‑term management is recommended, and at what blood pressure thresholds should therapy be initiated?

Acute Severe Hypertension Management

The critical first step is determining whether acute target organ damage is present—this single distinction dictates everything: patients WITH organ damage (hypertensive emergency) require ICU admission and immediate IV therapy, while those WITHOUT organ damage should receive oral medications and outpatient follow-up, NOT aggressive acute lowering. 1

Initial Evaluation: The Make-or-Break Assessment

When someone presents with BP >180/120 mm Hg, immediately assess for acute target organ damage:

Look for these specific signs:

• Cardiac: Acute heart failure, pulmonary edema, acute coronary syndrome
• Neurologic: Encephalopathy, intracranial hemorrhage, acute ischemic stroke
• Renal: Acute kidney injury, hematuria
• Vascular: Aortic dissection (most lethal)
• Retinal: Advanced retinopathy with hemorrhages, exudates, papilledema 1, 2

Critical pitfall: Do NOT treat the BP number alone. The presence or absence of organ damage completely changes management. 1

Short-Term Treatment: Two Completely Different Pathways

Pathway 1: Hypertensive Emergency (WITH Organ Damage)

Admit to ICU immediately for continuous BP monitoring and parenteral therapy 1

BP Reduction Targets (time-sensitive):

• With compelling conditions (aortic dissection): Reduce SBP to <120 mm Hg within first hour 1
• With other compelling conditions: Reduce SBP to <140 mm Hg within first hour 1
• Without compelling conditions:
  • Reduce by no more than 25% in first hour
  • Then to <160/100 mm Hg over next 2-6 hours
  • Then cautiously to 130-140 mm Hg over 24-48 hours 1

Why this gradual approach? Rapid BP correction in longstanding hypertension causes vital organ hypoperfusion due to loss of autoregulation—you can cause stroke or MI by dropping BP too fast 1

Preferred IV agents:

• Nicardipine or clevidipine (short-acting, titratable calcium channel blockers)
• Labetalol (combined alpha/beta blocker)
• Selection depends on specific organ damage and comorbidities 1

Pathway 2: Severe Hypertension WITHOUT Organ Damage (Previously "Hypertensive Urgency")

Do NOT admit to ICU. Do NOT give IV medications. Do NOT aggressively lower BP acutely. 1

This is a Class 3 (Harm) recommendation—aggressive acute lowering in hospitalized patients with severe hypertension but no organ damage increases cardiovascular events, acute kidney injury, and hospitalization length 1, 3

Instead:

• Reinitiate or intensify oral antihypertensive medications
• Preferably manage in outpatient setting
• Brief observation period, then discharge 1

Most common cause: Medication nonadherence 3

Long-Term Management

Start or restart oral combination therapy:

• ACE inhibitor or ARB
• Thiazide diuretic
• Calcium channel blocker 3, 4

Essential components:

• Out-of-office BP monitoring (home or ambulatory)
• Investigate barriers to adherence
• Close follow-up until goal BP achieved 3

Evaluate for secondary hypertension if:

• Resistant hypertension despite 3+ drugs
• Progressive BP elevation
• Age <30 years at onset
• Evidence of premature target organ damage 3

Treatment Thresholds: Who Gets Treated?

Immediate treatment (ICU, IV therapy):

• BP >180/120 mm Hg PLUS acute organ damage 1

Urgent outpatient treatment (oral agents):

• BP >180/120 mm Hg WITHOUT organ damage 1

Special threshold for referral from primary care:

• Headache or visual disturbances alone: Refer only if BP >200/120 mm Hg
• Symptoms suggesting organ damage (chest pain, dyspnea): Always refer regardless of BP reading 5

Key Clinical Pearls

The 10-30% mortality reality: Hypertensive emergencies carry 10% in-hospital mortality and 20-30% one-year cardiovascular morbidity/mortality 1. This is why the distinction matters.

Treat patients, not numbers: A BP of 200/120 mm Hg in an asymptomatic patient with chronic hypertension is managed completely differently than the same BP with pulmonary edema 6

The evidence gap: There are NO RCTs showing antihypertensive drugs reduce mortality in hypertensive emergencies—recommendations are based on observational data and physiologic principles 1

Common mistake in hospitalized patients: Transient BP elevations from anxiety, pain, or hypervolemia are often overtreated with short-acting IV agents, causing harm 3. Address the underlying trigger instead.